JP6650276B2 - Antibacterial pigment and antibacterial composition - Google Patents
Antibacterial pigment and antibacterial composition Download PDFInfo
- Publication number
- JP6650276B2 JP6650276B2 JP2016009352A JP2016009352A JP6650276B2 JP 6650276 B2 JP6650276 B2 JP 6650276B2 JP 2016009352 A JP2016009352 A JP 2016009352A JP 2016009352 A JP2016009352 A JP 2016009352A JP 6650276 B2 JP6650276 B2 JP 6650276B2
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- powder
- pigment
- treatment
- palmitoleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 76
- 239000000049 pigment Substances 0.000 title claims description 49
- 239000000203 mixture Substances 0.000 title claims description 24
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical class CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 50
- 239000000843 powder Substances 0.000 claims description 49
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 25
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims description 25
- 241000894006 Bacteria Species 0.000 claims description 19
- 241000191967 Staphylococcus aureus Species 0.000 claims description 18
- 229910052751 metal Chemical class 0.000 claims description 11
- 239000002184 metal Chemical class 0.000 claims description 11
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 10
- 206010000496 acne Diseases 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 7
- 238000011282 treatment Methods 0.000 description 27
- 238000000034 method Methods 0.000 description 13
- -1 Methyl hydrogen Chemical compound 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 125000001475 halogen functional group Chemical group 0.000 description 7
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000010445 mica Substances 0.000 description 6
- 229910052618 mica group Inorganic materials 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000010419 fine particle Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010049752 Peau d'orange Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000036232 cellulite Effects 0.000 description 2
- 229910000420 cerium oxide Inorganic materials 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- NNNVXFKZMRGJPM-UHFFFAOYSA-N hexadec-6-enoic acid Chemical compound CCCCCCCCCC=CCCCCC(O)=O NNNVXFKZMRGJPM-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- DDJSWKLBKSLAAZ-UHFFFAOYSA-N cyclotetrasiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]1 DDJSWKLBKSLAAZ-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000012756 surface treatment agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、皮膚の炎症原因菌に対して優れた抗菌効果を発揮する抗菌性顔料及び抗菌性組成物に関するものである。 The present invention relates to an antibacterial pigment and an antibacterial composition exhibiting an excellent antibacterial effect on inflammatory causative bacteria of the skin.
黄色ブドウ球菌(Staphylococcus aureus)は病原性を有しており、手に付いた菌が食品に付着して増殖し、これを食べることによる食中毒を引き起こす原因となることで良く知られている。また、通常の皮膚にも存在しており、皮膚が乾燥したり、肌荒れの状態となっている場合や、特に、アトピー性皮膚炎患者の皮膚上や創傷などによる炎症部位では、黄色ブドウ球菌が多く存在し、黄色ブドウ球菌の産生する毒素や抗原などによってアトピー性皮膚炎及び炎症反応が悪化する事も知られている。さらに黄色ブドウ球菌の産生する毒素は表皮細胞の増殖を促進し、皮膚の乾燥、肌荒れ等の形成及び悪化を引き起こす事がある。 Staphylococcus aureus is known to have pathogenicity, and that bacteria attached to the hands adhere to food and proliferate, causing food poisoning by eating the food. Staphylococcus aureus is also present on normal skin, and when the skin is dry or rough, and especially on inflamed sites such as on the skin or wounds of patients with atopic dermatitis. It is known that atopic dermatitis and inflammatory response are exacerbated by toxins and antigens produced by Staphylococcus aureus. Furthermore, the toxin produced by Staphylococcus aureus promotes the proliferation of epidermal cells and may cause the formation and deterioration of skin dryness and rough skin.
かねてより黄色ブドウ球菌の増殖を防ぐ安全性の高い抗菌・殺菌剤の開発が望まれ、α−D−グリコピラノシルグリセロール(特許文献1参照)やある種の脂肪酸などが優れた効果を発揮することが近年明らかになってきた(特許文献2参照)。特に脂肪酸の中でも炭素数10〜18の分岐飽和脂肪酸、6−ヘキサデセン酸、パルミトレイン酸、リノール酸などは健常な皮膚表面に存在する表皮ブドウ球菌には増殖作用を示し、黄色ブドウ球菌には殺菌・増殖阻害を示すことが知られている(特許文献3参照)。また、パルミトレイン酸のカルシウム塩は、即効性の殺菌効果と持続性に優れ、さらには黄色ブドウ球菌だけでなくアクネ菌(Propionibacterium acnes)等への選択殺菌性を示すことから身体洗浄料やスキンケア化粧料への応用が期待されている(特許文献4参照)。 It has been desired to develop a highly safe antibacterial / bactericidal agent that prevents the growth of Staphylococcus aureus, and α-D-glycopyranosylglycerol (see Patent Document 1) and certain fatty acids exhibit excellent effects. Has recently become clear (see Patent Document 2). In particular, among fatty acids, branched saturated fatty acids having 10 to 18 carbon atoms, 6-hexadecenoic acid, palmitoleic acid, linoleic acid, etc. show a proliferative effect on Staphylococcus epidermidis present on the surface of healthy skin, and disinfect against Staphylococcus aureus. It is known to exhibit growth inhibition (see Patent Document 3). In addition, the calcium salt of palmitoleic acid is excellent in immediate bactericidal effect and persistence, and further exhibits selective bactericidal properties not only on Staphylococcus aureus but also on acne bacteria (Propionibacterium acnes). It is expected to be applied to materials (see Patent Document 4).
しかし、メイクアップ化粧料においては、肌への影響や処方配合上の困難さなどからあまり配合が検討されてこなかった。アトピー性皮膚炎などでバリア機能の弱ってしまった肌で悩んでいる女性の中には、刺激に敏感であるため化粧を施すことに抵抗を示す人は多い。そこで、メイクアップしながらも菌等の外部刺激から確実に肌を守り、かつ効果的に肌を健常な状態に導いてくれるものなどが必要であるが、未だ提案されていないのが現状である。 However, in makeup cosmetics, formulation has not been studied so much because of effects on the skin and difficulty in formulating. Many women who are worried about skin whose barrier function has weakened due to atopic dermatitis, etc., are sensitive to irritation and show resistance to applying makeup. Therefore, something that protects the skin reliably from external stimuli such as bacteria while making up and that effectively leads the skin to a healthy state is necessary, but it has not been proposed yet. .
本発明は、上記事情に鑑みてなされたものであり、肌への付着性(持続性)に優れるとともに、黄色ブドウ球菌及びアクネ菌に対して高い抗菌性を示し、しかも化粧料等に無理なく配合することができる抗菌性顔料を提供すること、さらには該抗菌性顔料を配合した抗菌性組成物を提供することを目的とするものである。 The present invention has been made in view of the above circumstances, has excellent adhesiveness (persistence) to the skin, exhibits high antibacterial properties against Staphylococcus aureus and acne bacteria, and can be easily applied to cosmetics and the like. It is an object of the present invention to provide an antibacterial pigment that can be blended, and to further provide an antibacterial composition containing the antibacterial pigment.
前記目的を達成するために本発明者らは鋭意研究を行った結果、脂肪酸殺菌剤であるパルミトレイン酸を顔料粉体表面に担持させることにより、黄色ブドウ球菌及びアクネ菌に対して高い抗菌性を示す抗菌性顔料が得られ、該抗菌性顔料を配合した組成物でも同様の抗菌効果が得られることを見出し、本発明を完成させるに至ったものである。 In order to achieve the above object, the present inventors have conducted intensive studies and found that by supporting palmitoleic acid, a fatty acid bactericide, on the surface of pigment powder, high antibacterial properties against Staphylococcus aureus and Acne bacteria were achieved. The antibacterial pigments shown in the drawings were obtained, and it was found that the same antibacterial effect can be obtained even with a composition containing the antibacterial pigments, thereby completing the present invention.
要するに、第1発明による抗菌性顔料は、黄色ブドウ球菌及びアクネ菌に対して抗菌性を有するパルミトレイン酸又はその金属塩を顔料粉体表面に担持させてなることを特徴とするものである。 In short, the antibacterial pigment according to the first invention is characterized in that palmitoleic acid or a metal salt thereof having antibacterial activity against Staphylococcus aureus and Acne is carried on the surface of the pigment powder.
次に、第2発明による抗菌性組成物は、第1発明に係る抗菌性顔料を含有することを特徴とするものである。 Next, the antibacterial composition according to the second invention contains the antibacterial pigment according to the first invention.
本発明の抗菌性顔料によれば、黄色ブドウ球菌及びアクネ菌に対して抗菌性を有するパルミトレイン酸又はその金属塩が顔料粉体表面に担持されるので、肌への付着性(持続性)に優れるとともに、黄色ブドウ球菌及びアクネ菌に対して高い抗菌性を示し、しかも化粧料等に無理なく配合することができる。かかる抗菌性顔料は肌への付着性が向上しているため、この抗菌性顔料を含有する抗菌性組成物は、抗菌効果が長時間持続するものとなる。 According to the antibacterial pigment of the present invention, palmitoleic acid or a metal salt thereof having antibacterial properties against Staphylococcus aureus and Acne is carried on the surface of the pigment powder, so that adhesion to skin (persistence) is improved. It is excellent and shows high antibacterial properties against Staphylococcus aureus and Acne bacteria, and can be blended into cosmetics and the like without difficulty. Since the antibacterial pigment has improved adhesion to the skin, the antibacterial composition containing the antibacterial pigment has a long-lasting antibacterial effect.
次に、本発明による抗菌性顔料及び抗菌性組成物の具体的な実施の形態について説明する。 Next, specific embodiments of the antibacterial pigment and the antibacterial composition according to the present invention will be described.
本発明の抗菌性顔料を得るための処理方法としては、パルミトレイン酸を適当な有機溶剤に溶解又は分散させ、その混合液を所望の顔料粉体と攪拌混合した後、有機溶剤を除去することで、顔料粉体表面にパルミトレイン酸が担持された顔料を得ることができる。 As a treatment method for obtaining the antibacterial pigment of the present invention, palmitoleic acid is dissolved or dispersed in an appropriate organic solvent, and the mixture is stirred and mixed with a desired pigment powder, and then the organic solvent is removed. Thus, a pigment in which palmitoleic acid is supported on the surface of the pigment powder can be obtained.
本発明におけるパルミトレイン酸は、由来は特に限定されず、天然であっても、合成であってもよく、更にこれらのパルミトレイン酸の金属塩であってもよい。パルミトレイン酸の金属塩としては、例えば、カルシウム塩、ナトリウム塩、カリウム塩、マグネシウム塩、アルミニウム塩等を挙げることができ、中でもカルシウム塩を好適に例示することができる。これらのパルミトレイン酸の金属塩は、単独で用いてもよく、2種以上を混合して用いてもよい。 The origin of the palmitoleic acid in the present invention is not particularly limited, and may be natural or synthetic, and may be a metal salt of these palmitoleic acids. Examples of the metal salt of palmitoleic acid include a calcium salt, a sodium salt, a potassium salt, a magnesium salt, and an aluminum salt. Among them, a calcium salt can be preferably exemplified. These metal salts of palmitoleic acid may be used alone or in combination of two or more.
ここで用いられる有機溶剤としては、例えば、エタノール、イソプロピルアルコール、イソブタノール等のアルコール類、トルエン、n−ヘキサン、シクロヘキサン等の炭化水素系有機溶剤、アセトン、酢酸エチル、酢酸ブチル等の極性有機溶剤などが挙げられる。 Examples of the organic solvent used herein include alcohols such as ethanol, isopropyl alcohol and isobutanol, hydrocarbon organic solvents such as toluene, n-hexane and cyclohexane, and polar organic solvents such as acetone, ethyl acetate and butyl acetate. And the like.
また、混合分散方法としては、溶剤の濃度や粘度などに応じて適当な方法を選択することができ、好適な例としては、ディスパー、ヘンシェルミキサー、レディゲミキサー、ニーダー、V型混合機、ロールミル、ビーズミル、2軸混練機等の混合機による方法や、水溶液と顔料を加熱空気中に噴霧して水分を一気に除去するスプレードライなどの方法を選択することができる。また、粉砕を行う場合においては、ハンマーミル、ボールミル、サイドミル、ジェットミル等の通常の粉砕機を用いることができ、いずれの粉砕機によっても同等の品質のものが得られるため、特に限定されるものではない。 Further, as the mixing and dispersing method, an appropriate method can be selected according to the concentration and viscosity of the solvent, and preferable examples thereof include Disper, Henschel mixer, Loedige mixer, kneader, V-type mixer, and roll mill. A method using a mixer such as a bead mill or a twin-screw kneader, or a method such as spray drying in which an aqueous solution and a pigment are sprayed into heated air to remove water at a stroke can be selected. In the case of performing pulverization, a normal pulverizer such as a hammer mill, a ball mill, a side mill, and a jet mill can be used, and the same quality can be obtained with any pulverizer. Not something.
パルミトレイン酸の顔料粉体表面への付着又は被覆量は、特に限定されるものではないが、目的とする抗菌効果を示し、優れた付着性と耐水性を得るには、0.1質量%以上30質量%以下であるのが望ましい。前記被覆量が0.1質量%未満であると抗菌効果と持続性が十分でなく、30質量%を超えると感触が非常に悪くなり、化粧品としては適さない。 The amount of palmitoleic acid adhering to or covering the pigment powder surface is not particularly limited, but is 0.1% by mass or more in order to exhibit the desired antibacterial effect and to obtain excellent adhesion and water resistance. The content is desirably 30% by mass or less. If the coating amount is less than 0.1% by mass, the antibacterial effect and the sustainability are not sufficient, and if it exceeds 30% by mass, the feel becomes very poor, and it is not suitable for cosmetics.
本発明において、表面処理時に従来公知の他の表面処理剤を使用して、同時、又は多重の表面処理を行っても構わない。従来公知の表面処理の例としては、例えばフッ素化合物処理(パーフルオロアルキルリン酸エステル処理やパーフルオロアルキルシラン処理、パーフルオロポリエーテル処理、フルオロシリコーン処理、フッ素化シリコーン樹脂処理など)、シリコーン処理(メチルハイドロジェンポリシロキサン処理、ジメチルポリシロキサン処理、気相法テトラメチルテトラハイドロジェンシクロテトラシロキサン処理など)、シリコーン樹脂処理(トリメチルシロキシケイ酸処理など)、ペンダント処理(気相法シリコーン処理後にアルキル鎖などを付加する方法)、シランカップリング剤処理、チタンカップリング剤処理、アルミニウムカップリング剤処理、シラン処理(アルキル化シランやアルキル化シラザン処理など)、油剤処理、ポリアクリル酸処理、金属石鹸処理(ステアリン酸塩やミリスチン酸塩処理など)、水添レシチン処理、アクリル樹脂処理、金属酸化物処理などが挙げられ、またこれらの処理を複数組み合わせて用いることも可能である。 In the present invention, at the time of surface treatment, other conventionally known surface treatment agents may be used for simultaneous or multiple surface treatment. Examples of conventionally known surface treatments include, for example, fluorine compound treatment (perfluoroalkylphosphate treatment, perfluoroalkylsilane treatment, perfluoropolyether treatment, fluorosilicone treatment, fluorinated silicone resin treatment, etc.), silicone treatment ( Methyl hydrogen polysiloxane treatment, dimethyl polysiloxane treatment, vapor phase tetramethyltetrahydrogen cyclotetrasiloxane treatment, etc.), silicone resin treatment (trimethylsiloxysilicic acid treatment, etc.), pendant treatment (gas chain silicone treatment followed by alkyl chain Method, silane coupling agent treatment, titanium coupling agent treatment, aluminum coupling agent treatment, silane treatment (alkylated silane or alkylated silazane treatment, etc.), oil treatment, polyacrylic Treatment, metal soap treatment (such as stearate or myristate treated), hydrogenated lecithin treated, acrylic resin treatment, may be mentioned a metal oxide treatment, also may be used by combining a plurality of these processes.
パルミトレイン酸にて被覆される顔料としては、従来公知の顔料を使用することができ、その形状(球状、棒状、針状、板状、不定形状、鱗片状、紡錘状等)や粒子径(煙霧状、微粒子、顔料級等)、粒子構造(多孔質、無孔質等)を問わず、いろいろなものを使用することができる。例えば無機粉体、有機粉体、有色顔料、パール顔料、金属粉末顔料等が挙げられる。 As the pigment coated with palmitoleic acid, conventionally known pigments can be used, and the shape (spherical shape, rod shape, needle shape, plate shape, irregular shape, scale shape, spindle shape, etc.) and particle size (fume Irrespective of the shape, fine particles, pigment grade, etc.) and the particle structure (porous, non-porous, etc.). For example, inorganic powder, organic powder, colored pigment, pearl pigment, metal powder pigment and the like can be mentioned.
具体的には、無機粉体としては、例えば、酸化チタン、酸化ジルコニウム、酸化亜鉛、酸化セリウム、酸化マグネシウム、硫酸バリウム、硫酸カルシウム、硫酸マグネシウム、炭酸カルシウム、炭酸マグネシウム、タルク、マイカ、カオリン、セリサイト、白雲母、合成雲母、金雲母、紅雲母、黒雲母、リチア雲母、ケイ酸、無水ケイ酸、ケイ酸アルミニウム、ケイ酸マグネシウム、ケイ酸アルミニウムマグネシウム、ケイ酸カルシウム、ケイ酸バリウム、ケイ酸ストロンチウム、タングステン酸金属塩、ヒドロキシアパタイト、バーミキュライト、ハイジライト、ベントナイト、モンモリロナイト、ヘクトライト、ゼオライト、セラミックスパウダー、第二リン酸カルシウム、アルミナ、水酸化アルミニウム、窒化ホウ素、窒化ボロン、シリカ等が挙げられる。 Specifically, examples of the inorganic powder include titanium oxide, zirconium oxide, zinc oxide, cerium oxide, magnesium oxide, barium sulfate, calcium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, talc, mica, kaolin, and cellulite. Site, muscovite, synthetic mica, phlogopite, rhombic mica, biotite, lithia mica, silicic acid, silicic anhydride, aluminum silicate, magnesium silicate, aluminum magnesium silicate, calcium silicate, barium silicate, silicate Strontium, metal tungstate, hydroxyapatite, vermiculite, heidilite, bentonite, montmorillonite, hectorite, zeolite, ceramic powder, dibasic calcium phosphate, alumina, aluminum hydroxide, boron nitride, boron nitride, silicon nitride Mosquitoes, and the like.
また、有機粉体としては、例えば、ポリアミドパウダー、ポリエステルパウダー、ポリエチレンパウダー、ポリプロピレンパウダー、ポリスチレンパウダー、ポリウレタンパウダー、ベンゾグアナミンパウダー、ポリメチルベンゾグアナミンパウダー、ポリテトラフルオロエチレンパウダー、ポリメチルメタクリレートパウダー、セルロース、シルクパウダー、ナイロンパウダー、12ナイロン、6ナイロン、アクリルパウダー、アクリルエラストマー、スチレン・アクリル酸共重合体、ジビニルベンゼン・スチレン共重合体、ビニル樹脂、尿素樹脂、フェノール樹脂、フッ素樹脂、ケイ素樹脂、アクリル樹脂、メラミン樹脂、エポキシ樹脂、ポリカーボネイト樹脂、微結晶繊維粉体、デンプン末、ラウロイルリジン等が挙げられる。 Further, as the organic powder, for example, polyamide powder, polyester powder, polyethylene powder, polypropylene powder, polystyrene powder, polyurethane powder, benzoguanamine powder, polymethylbenzoguanamine powder, polytetrafluoroethylene powder, polymethyl methacrylate powder, cellulose, silk Powder, nylon powder, 12 nylon, 6 nylon, acrylic powder, acrylic elastomer, styrene / acrylic acid copolymer, divinylbenzene / styrene copolymer, vinyl resin, urea resin, phenol resin, fluororesin, silicon resin, acrylic resin Melamine resin, epoxy resin, polycarbonate resin, microcrystalline fiber powder, starch powder, lauroyl lysine, and the like.
さらに、有色顔料としては、例えば、酸化鉄、水酸化鉄、チタン酸鉄の無機赤色顔料、γ−酸化鉄等の無機褐色系顔料、黄酸化鉄、黄土等の無機黄色系顔料、黒酸化鉄、カーボンブラック等の無機黒色顔料、マンガンバイオレット、コバルトバイオレット等の無機紫色顔料、水酸化クロム、酸化クロム、酸化コバルト、チタン酸コバルト等の無機緑色顔料、紺青、群青等の無機青色系顔料、微粒子酸化チタン、微粒子酸化セリウム、微粒子酸化亜鉛等の微粒子粉体、タール系色素をレーキ化したもの、天然色素をレーキ化したもの、及びこれらの粉体を複合化した合成樹脂粉体等が挙げられる。 Further, as the colored pigments, for example, inorganic red pigments of iron oxide, iron hydroxide, iron titanate, inorganic brown pigments such as γ-iron oxide, yellow iron oxide, inorganic yellow pigments such as loess, black iron oxide , Inorganic black pigments such as manganese violet and cobalt violet, inorganic green pigments such as chromium hydroxide, chromium oxide, cobalt oxide, and cobalt titanate; inorganic blue pigments such as navy blue and ultramarine blue; and fine particles. Fine particle powders such as titanium oxide, fine particle cerium oxide, and fine particle zinc oxide, those obtained by laked tar dyes, those obtained by laked natural dyes, and synthetic resin powders obtained by compounding these powders. .
また、パール顔料としては、例えば、酸化チタン被覆雲母、酸化チタン被覆マイカ、オキシ塩化ビスマス、酸化チタン被覆オキシ塩化ビスマス、酸化チタン被覆タルク、魚鱗箔、酸化チタン被覆着色雲母等が挙げられる。 Examples of the pearl pigment include titanium oxide-coated mica, titanium oxide-coated mica, bismuth oxychloride, titanium oxide-coated bismuth oxychloride, titanium oxide-coated talc, fish scale foil, and titanium oxide-coated colored mica.
また、金属粉末顔料としては、例えば、アルミニウムパウダー、カッパーパウダー、ステンレスパウダー等から選ばれる粉体が挙げられる。 Examples of the metal powder pigments include powders selected from aluminum powder, copper powder, stainless powder, and the like.
本発明における抗菌性顔料の抗菌効果は、以下の方法で確認されたものである。試験法は、JIS L1902−2008(繊維製品の抗菌性試験方法及び抗菌効果)9定性試験(ハロー法)に準拠した抗菌性試験を用いた。菌を塗抹した寒天培地の中央に試験粉体を置き、この培地を32.5〜37℃で24時間放置し、培地上に菌が繁殖した状況で、試験粉体の周囲に菌が繁殖しない阻止帯(ハロー)の有無を確認し、抗菌効果を評価した。本発明の抗菌性顔料を用いて行った場合に、抗菌性顔料の周囲に菌が繁殖しない阻止帯が形成されるため、本発明の抗菌性顔料を配合した化粧組成物は、肌上で高い抗微生物性を維持できる。 The antibacterial effect of the antibacterial pigment in the present invention has been confirmed by the following method. As a test method, an antibacterial test based on JIS L1902-2008 (Antibacterial test method and antibacterial effect of textile products) 9 qualitative test (halo method) was used. The test powder is placed in the center of the agar medium coated with the bacteria, and the medium is left at 32.5 to 37 ° C. for 24 hours. In a situation where the bacteria have propagated on the medium, the bacteria do not propagate around the test powder. The presence or absence of a zone of inhibition (halo) was confirmed, and the antibacterial effect was evaluated. When performed using the antibacterial pigment of the present invention, since a zone of inhibition in which bacteria do not propagate around the antibacterial pigment is formed, the cosmetic composition containing the antibacterial pigment of the present invention has a high cosmetic composition. Can maintain antimicrobial properties.
次に、本発明に係る抗菌性組成物について説明する。本発明の組成物は、パルミトレイン酸を表面処理した顔料粉体(抗菌性顔料)を配合することによって、黄色ブドウ球菌及びアクネ菌に対する抗菌効果が得られる。剤型としては、クリーム、乳液、化粧水等のスキンケア製品、ファンデーション、口紅等のメイクアップ製品、紫外線防御製品、頭髪製品、制汗剤製品等に用いることができる。配合量は特に限定されないが、組成物の質量に対して0.1〜99質量%の範囲で配合することが可能であり、より好ましくは1〜80質量%の範囲である。 Next, the antibacterial composition according to the present invention will be described. The composition of the present invention can obtain an antibacterial effect against Staphylococcus aureus and Acne by mixing a pigment powder (antibacterial pigment) having a surface treated with palmitoleic acid. As the dosage form, it can be used for skin care products such as creams, emulsions, lotions, makeup products such as foundations and lipsticks, ultraviolet protection products, hair products, antiperspirant products and the like. The blending amount is not particularly limited, but can be blended in the range of 0.1 to 99% by mass, more preferably 1 to 80% by mass, based on the mass of the composition.
さらに、本発明の抗菌性組成物には、通常化粧料や医薬部外品に用いられる成分、例えば、粉体、界面活性剤、油剤、ゲル化剤、高分子、美容成分、保湿剤、色素、防腐剤、香料等を本発明の効果を損なわない範囲で使用することができる。 Further, the antimicrobial composition of the present invention includes components usually used in cosmetics and quasi-drugs, for example, powders, surfactants, oils, gelling agents, polymers, cosmetic ingredients, humectants, pigments , Preservatives, fragrances and the like can be used as long as the effects of the present invention are not impaired.
本発明の抗菌性組成物の形態としては、パウダー状、乳液状、クリーム状、スティック状、固型状、スプレー、多層分離型などいずれの剤型を用いても構わないが、より好ましくはパウダー状である。 As the form of the antibacterial composition of the present invention, any dosage form such as powder, emulsion, cream, stick, solid, spray, and multi-layer separation type may be used, but powder is more preferable. It is.
次に、本発明による抗菌性顔料及びその抗菌性顔料を配合した抗菌性組成物の実施例及び比較例に基づいて本発明をより具体的に説明するが、本発明は以下の実施例に限定されるものではない。なお、実施例中の%はすべて質量%を意味する。 Next, the present invention will be described more specifically based on examples and comparative examples of the antibacterial pigment according to the present invention and the antibacterial composition containing the antibacterial pigment, but the present invention is limited to the following examples. It is not something to be done. In addition, all% in an Example means a mass%.
(実施例1)
ミキサーにセリサイト100gを入れ、続いてパルミトレイン酸(商品名:cis−9−hexadecenoic acid、東京化成工業(株)製)5.0gをイソプロピルアルコール5.0gに溶解させた溶液を滴下混合し、セリサイトとよく混合した。その後、粉体をミキサーから取り出し、80℃で8時間真空乾燥後粉砕して、パルミトレイン酸が5%処理されたセリサイトを得た。同様の工程にて、球状セルロース粉体(商品名:CELLULOBEADS D−10、大東化成工業(株)製)に同様の表面被覆処理を施し、それぞれのサンプルを得た。
(Example 1)
100 g of sericite was put into a mixer, and a solution of 5.0 g of palmitoleic acid (trade name: cis-9-hexadecenoic acid, manufactured by Tokyo Chemical Industry Co., Ltd.) in 5.0 g of isopropyl alcohol was dropped and mixed. Mixed well with sericite. Thereafter, the powder was taken out of the mixer, vacuum-dried at 80 ° C. for 8 hours, and pulverized to obtain sericite treated with palmitoleic acid at 5%. In the same process, spherical cellulose powder (trade name: CELLULOBEADS D-10, manufactured by Daito Kasei Kogyo Co., Ltd.) was subjected to the same surface coating treatment to obtain respective samples.
(実施例2)
実施例1で製造した5%処理顔料と同様にして、パルミトレイン酸が10%処理されたセリサイト、ならびに球状セルロース粉体のサンプルを得た。
(Example 2)
In the same manner as the 5% -treated pigment prepared in Example 1, a sample of sericite treated with palmitoleic acid at 10% and a spherical cellulose powder were obtained.
(比較例1)
攪拌装置付き3Lビーカーに水1000gを入れ、続いてステアリン酸(商品名:LUNAC S−90V、花王(株)製)5.0gと水酸化ナトリウムを添加して加熱後、この水溶液中にセリサイト100gを入れ十分に攪拌分散させた。さらに塩化マグネシウム六水和物1.8gを添加混合し、酸溶液により中和を行い水洗濾過した。固形分を水分含量が1%以下になるまで乾燥させ、粉砕を行うことにより、ステアリン酸マグネシウムが5%処理されたセリサイトを得た。同様の工程にて、球状セルロース粉体(商品名:CELLULOBEADS D−10、大東化成工業(株)製)に同様の表面被覆処理を施し、それぞれのサンプルを得た。
(Comparative Example 1)
1000 g of water was put into a 3 L beaker equipped with a stirrer, 5.0 g of stearic acid (trade name: LUNAC S-90V, manufactured by Kao Corporation) and sodium hydroxide were added, and the mixture was heated. 100 g was added and sufficiently stirred and dispersed. Further, 1.8 g of magnesium chloride hexahydrate was added and mixed, neutralized with an acid solution, washed with water and filtered. The solid content was dried until the water content became 1% or less, and pulverized to obtain sericite treated with 5% of magnesium stearate. In the same process, spherical cellulose powder (trade name: CELLULOBEADS D-10, manufactured by Daito Kasei Kogyo Co., Ltd.) was subjected to the same surface coating treatment to obtain respective samples.
ここで、本実施例に係るパルミトレイン酸の表面処理粉体(抗菌性顔料)について、微生物に対する抗菌効果についての試験を行った。 Here, the surface-treated powder (antibacterial pigment) of palmitoleic acid according to the present example was tested for its antibacterial effect on microorganisms.
<抗菌性:黄色ブドウ球菌>
JIS L1902−2008(繊維製品の抗菌性試験方法及び抗菌効果)9定性試験(ハロー法)に準拠して抗菌性を評価した。試験菌を普通ブイヨン培地で1.0×108cfu/mLに調整し、10倍希釈した菌液をSCD寒天培地へ塗抹し、その中央に試験粉体0.2gを置く。32.5℃にて24時間培養し、阻止帯(ハロー)を観察した。試料の周囲に阻止帯のあるものは+とし、阻止帯のないものは−とした。
<Antibacterial: Staphylococcus aureus>
The antibacterial property was evaluated based on JIS L1902-2008 (Antibacterial property test method and antibacterial effect of textile products) 9 qualitative test (Halo method). The test bacterium is adjusted to 1.0 × 10 8 cfu / mL with a normal broth medium, and the 10-fold diluted bacterial solution is spread on an SCD agar medium, and 0.2 g of the test powder is placed at the center. And cultured for 24 hours at 32.5 ℃, it was observed deter band (halo). A sample having a stop band around the sample was marked as +, and a sample without a stop band was marked as-.
<抗菌性:アクネ菌>
JIS L1902−2008(繊維製品の抗菌性試験方法及び抗菌効果)9定性試験(ハロー法)に準拠して抗菌性を評価した。試験菌をGAM寒天培地で前々培養し、GAMブイヨン培地で前培養したものを1.7×10 7 cfu/mLに希釈した。GAM寒天培地へ塗抹し、その中央に試験粉体に少量の精製水を加えたものを置く。37℃にて48時間嫌気培養し、阻止帯(ハロー)を観察した。試料の周囲に阻止帯のあるものは+とし、阻止帯のないものは−とした。
表1に、実施例1,2のパルミトレイン酸処理セリサイト、球状セルロース粉体および比較例1のステアリン酸マグネシウム5%処理セリサイト、及びステアリン酸マグネシウム5%処理球状セルロース粉体の各菌種に対する抗菌効果の結果を示した。
<Antibacterial: Acne bacteria>
The antibacterial property was evaluated based on JIS L1902-2008 (Antibacterial property test method and antibacterial effect of textile products) 9 qualitative test (Halo method). The test bacteria were pre-cultured on a GAM agar medium, and those pre-cultured on a GAM broth medium were diluted to 1.7 × 10 7 cfu / mL. Smear onto GAM agar medium, and place in the center thereof a test powder to which a small amount of purified water has been added. 48 hours anaerobic culture at 37 ℃, was observed deter band (halo). A sample having a stop band around the sample was marked as +, and a sample without a stop band was marked as-.
Table 1 shows the cellulite treated with palmitoleic acid of Examples 1 and 2, the spherical cellulose powder, the sericite treated with 5% magnesium stearate of Comparative Example 1, and the spherical cellulose powder treated with 5% magnesium stearate with respect to each bacterial species. The results of antibacterial effect were shown.
実施例1のパルミトレイン酸5%処理セリサイトおよび球状セルロース粉体は、黄色ブドウ球菌及びアクネ菌に対する抗菌性を示した。処理量を10%に増やした実施例2では、それらの菌に対する抗菌性をより顕著に示した。比較例1のセリサイト及び球状セルロース粉体は、全ての菌に対して抗菌効果がなかった。 The 5% palmitoleic acid-treated sericite and spherical cellulose powder of Example 1 exhibited antibacterial properties against Staphylococcus aureus and Acne bacteria. In Example 2 in which the treatment amount was increased to 10%, the antibacterial activity against those bacteria was more remarkably exhibited. The sericite and spherical cellulose powder of Comparative Example 1 did not have an antibacterial effect on all bacteria.
次に、本発明の抗菌性組成物の実施例について説明する。 Next, examples of the antibacterial composition of the present invention will be described.
(実施例3:パルミトレイン酸表面処理顔料を用いたルースパウダー)
表2に示す全成分をブレンダーミキサーで混合した後、粉砕機を通して粉砕し、ふるいにかけて実施例3の抗菌性組成物を得た。
(Example 3: Loose powder using palmitoleic acid surface-treated pigment)
After mixing all the components shown in Table 2 with a blender mixer, the mixture was pulverized through a pulverizer and sieved to obtain the antibacterial composition of Example 3.
ここで、実施例3に係る抗菌性組成物について、微生物に対する殺菌効果についての試験を行った。試験方法は、実施例1,2に係るパルミトレイン酸処理粉体と同じ方法で行い、菌の種類は、黄色ブドウ球菌である。試料の周囲に阻止帯(ハロー)があれば+、なければ−とし、表3に結果を示した。 Here, the antibacterial composition according to Example 3 was tested for its bactericidal effect on microorganisms. The test method was performed in the same manner as the palmitoleic acid-treated powder according to Examples 1 and 2, and the type of the bacterium was Staphylococcus aureus. The result was shown in Table 3 as + when there was a stop band (halo) around the sample, and-when there was no band.
実施例3のパルミトレイン酸10%処理セリサイトおよび球状セルロース粉体を含有したルースパウダーは、黄色ブドウ球菌に対する抗菌性を示した。 Loose powder containing 10% of palmitoleic acid-treated sericite and spherical cellulose powder of Example 3 exhibited antibacterial activity against Staphylococcus aureus.
本発明の抗菌性顔料は、選択殺菌性を有しており、化粧料や医薬部外品に好適に配合して用いることができ、産業上の利用可能性が大である。
The antibacterial pigment of the present invention has selective bactericidal properties, can be suitably used in cosmetics and quasi-drugs, and has great industrial applicability.
Claims (4)
The antibacterial composition according to claim 3 , which is configured in a powder form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016009352A JP6650276B2 (en) | 2016-01-21 | 2016-01-21 | Antibacterial pigment and antibacterial composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016009352A JP6650276B2 (en) | 2016-01-21 | 2016-01-21 | Antibacterial pigment and antibacterial composition |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017128535A JP2017128535A (en) | 2017-07-27 |
JP2017128535A5 JP2017128535A5 (en) | 2018-12-20 |
JP6650276B2 true JP6650276B2 (en) | 2020-02-19 |
Family
ID=59396533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016009352A Active JP6650276B2 (en) | 2016-01-21 | 2016-01-21 | Antibacterial pigment and antibacterial composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6650276B2 (en) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3524169B2 (en) * | 1994-09-20 | 2004-05-10 | カネボウ株式会社 | Skin cosmetics for acne improvement |
JPH10101502A (en) * | 1996-09-25 | 1998-04-21 | Chichibu Onoda Cement Corp | Antimicrobial agent |
JP3503879B2 (en) * | 1999-07-07 | 2004-03-08 | 花王株式会社 | Cosmetics |
JP4776058B2 (en) * | 1999-10-06 | 2011-09-21 | サンスター株式会社 | Skin improver |
JP4220769B2 (en) * | 2002-12-10 | 2009-02-04 | 花王株式会社 | Anti-acne bacteria composition |
JP5473241B2 (en) * | 2008-03-31 | 2014-04-16 | ジェイカムアグリ株式会社 | Coated granules |
JP6203508B2 (en) * | 2013-03-07 | 2017-09-27 | 花王株式会社 | Fungicide |
CA2914583C (en) * | 2013-06-04 | 2019-06-18 | Vyome Biosciences Pvt. Ltd. | Coated particles and compositions comprising same |
-
2016
- 2016-01-21 JP JP2016009352A patent/JP6650276B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017128535A (en) | 2017-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5639067B2 (en) | Cosmetic pigment, method for producing the same, and cosmetic containing the cosmetic pigment | |
RU2142781C1 (en) | Composition for make-up of eyelashes and eyebrows, and agent for inhibiting microorganisms in cosmetic emulsions | |
TW200837152A (en) | Method for the hydrophobic treatment of pigment particles and the personal care compositions comprising said pigment particles | |
JP6591865B2 (en) | Cosmetic powder, its production method and cosmetics | |
JP2018108994A (en) | Oil-in-water emulsion composition | |
JP2010138110A (en) | Composition for external use, excellent in skin-concealing power | |
JP2009269866A (en) | Pigment for cosmetic and cosmetic comprising the same | |
JP2008143837A5 (en) | ||
JP2011037786A (en) | Cosmetic having sufficient antibacterial properties and excellent in moisture retention | |
JP5592095B2 (en) | Powder cosmetics | |
JPH06279235A (en) | Powdery solid cosmetic | |
JP2000159632A (en) | Skin antimicrobial composition | |
JP6650276B2 (en) | Antibacterial pigment and antibacterial composition | |
JP2008247877A (en) | Aqueous eye shadow | |
JP2012240999A (en) | Powder cosmetic | |
JP2003137731A (en) | Antimicrobial powder cosmetic and method for producing antimicrobial powder cosmetic | |
TW201900142A (en) | Oil-in-water emulsion composition | |
JPH10194929A (en) | Antimicrobial pigment for cosmetic, production of the pigment, and cosmetic composition containing the pigment | |
JPH10194953A (en) | Antibacterial cosmetic | |
JP2021155361A (en) | Fiber-containing cosmetic | |
JP2016210744A (en) | Surface-treated powder and cosmetic containing the powder | |
JP2014101279A (en) | Surface-treated powder and cosmetic compounded with the powder | |
JPS6351313A (en) | Powdery cosmetic | |
Shih et al. | Acidic Microenvironment–Sensitive Core-Shell Microcubes: The Self-assembled and the Therapeutic Effects for Caries Prevention | |
JPH11228346A (en) | Cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20181030 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181109 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181109 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190821 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190903 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190905 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200107 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200120 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6650276 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |